Literature DB >> 28979761

Visfatin level in children and adolescents with autoimmune thyroiditis.

Hekma Saad Farghaly1, Kotb Abbass Metwalley2, Faisal-Alkhateeb Ahmed1, Duaa Mohamed Raafat1, Osama El-Asheer1, Ahmed Mahmood Ali1, Ahlam Bahdawy1, Asmaa Mohamed Zahran3.   

Abstract

BACKGROUND: This study aims to assess the levels of visfatin in children and adolescents with autoimmune thyroiditis (AIT) and its relationship with disease-related variables.
METHODS: The study included 84 children and adolescents with AIT and 84 healthy subjects. Measurements of fasting glucose, insulin, thyroid-stimulating hormone (TSH), free thyroxin (FT4), antithyroid peroxidase antibodies (TPOAb) and antithyroglobulin antibody (TgAb) were completed, with assessment of visfatin levels.
RESULTS: Overt hypothyroidism was diagnosed in 58 cases, while subclinical hypothyroidism was diagnosed in 26 of the studied patients. Total studied cases, overt and subclinical subgroups had significantly higher levels of TSH, HOMA-IR, TPOAb, TgAb and visfatin and significantly lower FT4 level compared with the control. Spearman correlation analysis revealed that visfatin was correlated positively with BMI, homeostasis model assessment (HOMA-IR), TSH and TPOAb, while inversely correlation with FT4. In logistic regression analysis, visfatin was correlated only with TPOAb.
CONCLUSIONS: This preliminary study provides evidence of significantly higher level of visfatin in children and adolescents with AIT. Visfatin might have a potential role in the pathogenesis of AIT, which needs to be validated by measuring immunological responses in children and adolescents with AIT.

Entities:  

Keywords:  Autoimmune thyroiditis; Overt hypothyroidism; Subclinical hypothyroidism; Thyroid-stimulating hormone; Visfatin

Year:  2017        PMID: 28979761      PMCID: PMC5617091          DOI: 10.1177/2042018817731073

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  28 in total

1.  Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.

Authors:  Claudio Pagano; Catia Pilon; Massimiliano Olivieri; Paola Mason; Roberto Fabris; Roberto Serra; Gabriella Milan; Marco Rossato; Giovanni Federspil; Roberto Vettor
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

Review 2.  The role of apoptosis in thyroid autoimmunity.

Authors:  Su He Wang; James R Baker
Journal:  Thyroid       Date:  2007-10       Impact factor: 6.568

Review 3.  Adipokines influence the inflammatory balance in autoimmunity.

Authors:  Jack Hutcheson
Journal:  Cytokine       Date:  2015-06-01       Impact factor: 3.861

4.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

Authors:  Janin Berndt; Nora Klöting; Susan Kralisch; Peter Kovacs; Mathias Fasshauer; Michael R Schön; Michael Stumvoll; Matthias Blüher
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

5.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  J Clin Endocrinol Metab       Date:  2005-10-18       Impact factor: 5.958

6.  Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.

Authors:  Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Ding-Feng Su; Guo-Rong Fan; Chao-Yu Miao
Journal:  Cardiovasc Res       Date:  2008-10-24       Impact factor: 10.787

7.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

8.  Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease.

Authors:  Sandra A Rebuffat; Brigitte Nguyen; Bruno Robert; Françoise Castex; Sylvie Peraldi-Roux
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  Serum concentration of visfatin in obese women.

Authors:  Barbara Zahorska-Markiewicz; Magdalena Olszanecka-Glinianowicz; Joanna Janowska; Piotr Kocełak; Elzbieta Semik-Grabarczyk; Michał Holecki; Piotr Dabrowski; Anna Skorupa
Journal:  Metabolism       Date:  2007-08       Impact factor: 8.694

Review 10.  Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.

Authors:  Tracy Luk; Zeenat Malam; John C Marshall
Journal:  J Leukoc Biol       Date:  2008-02-05       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.